| 标题 |
Sarcopenia and high NLR are associated with the development of hyperprogressive disease after second-line pembrolizumab in patients with non-small-cell lung cancer |
| 网址 | |
| DOI | |
| 其它 |
期刊:Clinical and Experimental Immunology 作者:M P Petrova; I S Donev; M A Radanova; M I Eneva; E G Dimitrova; et al 出版日期:2020-08-06 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)